Xact Bio, Inc.

SEC filing

Biotechnology · Boston, MA

Form D on EDGAR

Amount raised$10Msold at filing

Total offering$18M$8M still open

Investors in the raise3count reported to the SEC

FiledSep 28, 2026first sale Sep 11, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Jian ShaoDirector

Chengjung LaiDirector

Uciane ScarlettExecutive Officer, Director

Eric GreenExecutive Officer, Director

Executive officers, directors and promoters as listed on the Form D.